Secondary prevention of sudden cardiac death

Neal A Chatterjee1, Thomas D Rea2

  • 1Electrophysiology Section, Cardiology Division, University of Washington, Seattle, Washington.

Heart Rhythm O2
|June 11, 2021
PubMed

Insights

Sudden cardiac death (SCD) prevention is key. Implantable cardioverter-defibrillators (ICDs) help high-risk patients, but ongoing management and new strategies are vital for improving outcomes and reducing mortality.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Public Health

Background:

  • Sudden cardiac death (SCD) poses a significant public health challenge.
  • Implantable cardioverter-defibrillators (ICDs) are crucial for secondary prevention in patients with ventricular arrhythmia history.
  • These patients face a high risk of recurrent arrhythmias and ICD therapies.

Purpose of the Study:

  • To review landmark trials on ICD efficacy in secondary prevention.
  • To analyze clinical outcomes, including mode of death in SCD survivors.
  • To discuss diagnostic evaluation and invasive electrophysiological management strategies.

Main Methods:

  • Literature review of landmark clinical trials.
  • Analysis of clinical outcomes and mode of death data.
  • Discussion of electrophysiological management, including ICD programming, antiarrhythmic drugs, and catheter ablation.

Main Results:

  • ICD therapy is a mainstay for secondary prevention but does not eliminate risk.
  • Understanding mode of death in survivors is critical for refining treatment.
  • Systematic diagnostic evaluation and tailored electrophysiological management are essential.

Conclusions:

  • Further research is needed to advance care for secondary prevention patients.
  • Optimizing ICD selection, programming, and adjunctive therapies (drugs, ablation) is crucial.
  • Addressing future challenges will improve outcomes for patients at risk of SCD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
109
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
432
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
93
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
111
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
188